Cargando…
Inhibition of K cell function by human breast cancer sera.
Sera from breast cancer patients and from female controls were tested for inhibition of lysis of antibody-coated target cells by human leukocytes (K cells). Sera from 39% of breast cancer patients, but from only 8% of controls, inhibited lysis by more than 30%. This inhibition was unrelated to the s...
Autores principales: | Matthews, N., Whitehead, R. H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1976
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2025226/ https://www.ncbi.nlm.nih.gov/pubmed/1008990 |
Ejemplares similares
-
Down-regulation of hK7 in the sera of breast cancer and benign breast disease patients
por: Ejaz, Samina, et al.
Publicado: (2017) -
Detection of human placental lactogen in sera and tumours of patients with fibroadenoma of breast.
por: Sheth, N. A., et al.
Publicado: (1981) -
Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis
por: Fernández Madrid, Félix, et al.
Publicado: (2015) -
Proceedings: Tumour antigen in human cancer patients' sera.
por: Bowen, J. G.
Publicado: (1975) -
Half-life of polybrominated biphenyl in human sera.
por: Rosen, D H, et al.
Publicado: (1995)